< p > November 1st, we clearly pointed out that: Shanghai Steel Union (300226, stock bar) quickly pulled up and closed up in the afternoon. Today's < a href= "http://m.pmae.cn/news/ > > /a > is the first time limit since October 10th. It has symbolic significance. Yesterday (November 4th), we put forward the environmental protection plate because the overall performance increased fairly well, and it highlighted the value in the weak environment, and also pointed out a direction for the weak market. From the stop of the mainstream sector (Internet) to the initiative of the strong leading plate (environmental protection), the second transmission of this much energy has formed an obvious conduction effect, and the rebound of today's growth enterprise market is also a matter of reason. < /p >
< p > in addition, Ju Feng Fan Bo, in his October 30th article, made it clear that as the gem appeared on the same day, it did not break through the suppression of the 5 day moving average, so it was not the beginning of the D wave rebound at that time. It was only the end of the fall. Today, Zhongyang's GEM has broken through the suppression of the 5 day moving average and directly went through the 10 day moving average, marking the official launch of the D wave rebound. < /p >
< p > < strong > repayment of debt, a variety or counterattack < /strong > < /p >
< p > the market entered the November, < a href= "http://m.pmae.cn/news/" > stocks < /a > the trap of paying debts is everywhere. On the one hand, from the recent market quotation, there are often missing opportunities in November: three quarterly reports have just passed, and the annual reports have not yet taken place, let alone the expectation of market capital tension caused by the settlement of funds at the end of the year. < /p >
When the market is in a weak cycle, there is always a piece of P that can give us some surprises. Especially, it can easily become a tool for organizations to warm up in a weak market. This plate is the medical sector. The main reason is that the demand for pharmaceutical products and services is relatively stable, which is a non cyclical plate. In particular, those pharmaceutical listed companies with complete industrial chain have prominent anti risk ability, and often lack of strong stocks. < /p >
< p > however, during this period of time, Baiyun Mountain (600332, stock bar) was falling down, Kun Lun Pharmaceutical (002422, stock bar) was frenzy, and Shu Tai Shen (300204, stock bar) faced the front valley. Yunnan Baiyao (000538, stock bar) had a razor walking tour, and the power of Tian Shi Li (600535, stock bar) was weak. Perhaps it is because the pharmaceutical companies also need to pay their debts, and have already paid their debts ahead of time or are paying their debts. < /p >
< p > but in November, it is still necessary to have a good view of < a href= "http://m.pmae.cn/news/" > pharmaceutical stocks < /a >, because November is destined to take medicine. If you don't take the medicine, what's the fate of the big boys? If you don't take the medicine, how will you spend the rest of your life in the future? < /p >
< p > if the medicine shares walk on the edge of razor to let everyone feel at a loss, then a medical grading index which does not need stock selection: medical B (150131) may solve this problem. Everyone's securities account is free to operate, T+1. The index fund's listing date is 2013-09-11, and in September, it completed a riot of up to 20%. In October, it completed a callback of up to 18%, highly demonstrating its active nature. < /p >
Less than P > more than 100000000, the premium is negative, and the small capital is suitable. < /p >
< p > recently, Ding Zhenyu, who has repeatedly stressed the investment opportunities of the Tianjin plate, has made a real red envelope. Will there be any surprises in the pharmaceutical B? Let's wait and see! < /p >